HQ Function

Served as the central hub for Orphazyme's research and development, clinical operations, corporate strategy, and administrative functions during its operational years.

Notable Features:

The facility likely comprised modern office spaces and potentially laboratory facilities equipped for biopharmaceutical research, typical for companies in the Medicon Valley cluster.

Work Culture:

The work culture at Orphazyme was likely driven by a strong scientific focus, a mission-oriented approach to addressing rare diseases, and a collaborative environment essential for drug development.

HQ Significance:

This headquarters was the nerve center for Orphazyme's global efforts to develop and seek approval for arimoclomol, coordinating international clinical trials and regulatory submissions.

Values Reflected in HQ: The headquarters aimed to embody Orphazyme's commitment to scientific innovation, patient-centricity in rare diseases, and perseverance in tackling complex medical challenges.

Location:

Historically, Orphazyme's global presence was primarily characterized by its extensive clinical trial programs for arimoclomol, which were conducted across numerous sites in North America and Europe. The company actively engaged with international regulatory authorities, including the U.S. FDA and the European Medicines Agency (EMA), and collaborated with a global network of researchers, medical institutions, and patient organizations focused on rare neurodegenerative diseases.

Street Address:

Ole Maaløes Vej 3

City:

Copenhagen

State/Province:

Capital Region of Denmark

Country:

Denmark